Literature DB >> 28776569

FBXO4 inhibits lung cancer cell survival by targeting Mcl-1 for degradation.

C Feng1, F Yang1, J Wang1.   

Abstract

Mcl-1 (myeloid cell leukemia 1) is a prosurvival member of the Bcl-2 family and plays a critical role in cell survival by suppressing apoptosis through inhibiting the activity of proapoptotic proteins. It has been reported that Mcl-1 is frequently overexpressed in lung cancer. However, the exact molecular mechanism underlying Mcl-1 elevation in lung cancer is largely unknown. Here, we reported that Mcl-1 protein levels inversely correlate with FBXO4 expression, but not other F-box proteins examined, in lung cancer cell lines and lung cancer patient samples. Mechanically, FBXO4 is the E3 ubiquitin ligase to interact with and promote Mcl-1 ubiquitination and degradation. As a result, knockdown of Fbxo4 dramatically elevates Mcl-1 protein levels and increases cell survival and resistance to chemotherapeutic drugs, whereas ectopic expression of FBXO4 displays opposite phenotypes. Therefore, our study suggests that the protein stability of Mcl-1 is governed by FBXO4, which plays an important role in cell survival and chemotherapy for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28776569     DOI: 10.1038/cgt.2017.24

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  40 in total

Review 1.  Proteolysis: from the lysosome to ubiquitin and the proteasome.

Authors:  Aaron Ciechanover
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

Review 2.  Protein degradation by the ubiquitin-proteasome pathway in normal and disease states.

Authors:  Stewart H Lecker; Alfred L Goldberg; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

3.  MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.

Authors:  K M Kozopas; T Yang; H L Buchan; P Zhou; R W Craig
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

Review 4.  Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis.

Authors:  Jinho Heo; Rebeka Eki; Tarek Abbas
Journal:  Semin Cancer Biol       Date:  2015-09-30       Impact factor: 15.707

Review 5.  Delving deeper: MCL-1's contributions to normal and cancer biology.

Authors:  Rhonda M Perciavalle; Joseph T Opferman
Journal:  Trends Cell Biol       Date:  2012-09-28       Impact factor: 20.808

6.  Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization.

Authors:  Qingqing Ding; Xianghuo He; Jung-Mao Hsu; Weiya Xia; Chun-Te Chen; Long-Yuan Li; Dung-Fang Lee; Jaw-Ching Liu; Qing Zhong; Xiaodong Wang; Mien-Chie Hung
Journal:  Mol Cell Biol       Date:  2007-03-26       Impact factor: 4.272

7.  Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.

Authors:  Douglas I Lin; Olena Barbash; K G Suresh Kumar; Jason D Weber; J Wade Harper; Andres J P Klein-Szanto; Anil Rustgi; Serge Y Fuchs; J Alan Diehl
Journal:  Mol Cell       Date:  2006-11-03       Impact factor: 17.970

8.  Up-regulation of Mcl-1 is critical for survival of human melanoma cells upon endoplasmic reticulum stress.

Authors:  Chen Chen Jiang; Keryn Lucas; Kelly A Avery-Kiejda; Margaret Wade; Charles E deBock; Rick F Thorne; John Allen; Peter Hersey; Xu Dong Zhang
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

9.  Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.

Authors:  M M Borner; P Brousset; B Pfanner-Meyer; M Bacchi; S Vonlanthen; M A Hotz; H J Altermatt; D Schlaifer; J C Reed; D C Betticher
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

10.  Mcl-1 ubiquitination: unique regulation of an essential survival protein.

Authors:  Barbara Mojsa; Iréna Lassot; Solange Desagher
Journal:  Cells       Date:  2014-05-08       Impact factor: 6.600

View more
  11 in total

1.  MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer.

Authors:  Xiaowei Wu; Qingyu Luo; Pengfei Zhao; Wan Chang; Yating Wang; Tong Shu; Fang Ding; Bin Li; Zhihua Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

Review 2.  Cyclin D degradation by E3 ligases in cancer progression and treatment.

Authors:  Shuo Qie; J Alan Diehl
Journal:  Semin Cancer Biol       Date:  2020-01-30       Impact factor: 15.707

3.  Mcl-1 and Bok transmembrane domains: Unexpected players in the modulation of apoptosis.

Authors:  Estefanía Lucendo; Mónica Sancho; Fabio Lolicato; Matti Javanainen; Waldemar Kulig; Diego Leiva; Gerard Duart; Vicente Andreu-Fernández; Ismael Mingarro; Mar Orzáez
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-22       Impact factor: 11.205

4.  The regulation of neuronal autophagy and cell survival by MCL1 in Alzheimer's disease.

Authors:  Abdol-Hossein Rezaeian; Wenyi Wei; Hiroyuki Inuzuka
Journal:  Acta Mater Med       Date:  2022-01-28

Review 5.  The E3 Ubiquitin Ligase Fbxo4 Functions as a Tumor Suppressor: Its Biological Importance and Therapeutic Perspectives.

Authors:  Shuo Qie
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

Review 6.  Saga of Mcl-1: regulation from transcription to degradation.

Authors:  Viacheslav V Senichkin; Alena Y Streletskaia; Anna S Gorbunova; Boris Zhivotovsky; Gelina S Kopeina
Journal:  Cell Death Differ       Date:  2020-01-06       Impact factor: 15.828

7.  Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer.

Authors:  Xinfang Yu; Li Zhou; Wenbin Liu; Lijun Liu; Feng Gao; Wei Li; Haidan Liu
Journal:  Cell Death Dis       Date:  2022-03-18       Impact factor: 9.685

Review 8.  Ubiquitination and deubiquitination of MCL1 in cancer: deciphering chemoresistance mechanisms and providing potential therapeutic options.

Authors:  Xiaowei Wu; Qingyu Luo; Zhihua Liu
Journal:  Cell Death Dis       Date:  2020-07-22       Impact factor: 8.469

Review 9.  F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

Authors:  Dinesh Singh Tekcham; Di Chen; Yu Liu; Ting Ling; Yi Zhang; Huan Chen; Wen Wang; Wuxiyar Otkur; Huan Qi; Tian Xia; Xiaolong Liu; Hai-Long Piao; Hongxu Liu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

10.  Clinical Relevance of Secreted Small Noncoding RNAs in an Embryo Implantation Potential Prediction at Morula and Blastocyst Development Stages.

Authors:  Angelika V Timofeeva; Ivan S Fedorov; Maria A Shamina; Vitaliy V Chagovets; Nataliya P Makarova; Elena A Kalinina; Tatiana A Nazarenko; Gennady T Sukhikh
Journal:  Life (Basel)       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.